I have a life sciences litigation practice with a focus on patent contentious proceedings (PTAB, district court, and on appeal to the Federal Circuit). Since the beginning of my career.
Published January 8, 2021 7:03pm The Philippines Food and Drug Administration approved Friday the clinical trial for the coronavirus disease 2019 (COVID-19) vaccine developed by Chinese firm Clover Biopharmaceuticals AUS Pty Ltd. Press Statement || Updates on Applications for Conduct of Clinical Trials and Emergency Use Authorization of COVID-19. Posted by Food and Drug Administration Philippines on Friday, January 8, 2021 Before securing the go signal from FDA, the Department of Science and Technology – Vaccine Expert Panel (DOST-VEP) and the Single Joint Ethics Review Board (SJREB) gave clearance to Clover Biopharma for the conduct of the clinical trial. In December 2020, the FDA approved the clinical trial on the vaccine developed by Janssen Vaccines & Prevention B.V.